Clinical Trial Update: Cross-linked and Non-cross-linked Hyaluronic Acid in Subdeltoid Bursitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating cross-linked and non-cross-linked hyaluronic acid for subdeltoid bursitis; recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdeltoid Bursitis

Drugs mentioned

• Cross-linked hyaluronic acid (Hyaluronic acid (cross-linked))
• Non-cross-linked hyaluronic acid (Hyaluronic acid (non-cross-linked))

Snippet

Sponsor: Taipei Medical University | Conditions: Subdeltoid Bursitis, Hyaluronic Acid | Phase 4 | Status: NOT_YET_RECRUITING